MétaCan
Menu
Back to cohort
Record W4385520471 · doi:10.3389/fcvm.2023.1204071

Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE

2023· article· en· W4385520471 on OpenAlexfundno aff
Andrew J. Buckler, Gheorghe Doros, April Kinninger, Suvasini Lakshmanan, Viet T. Le, Peter Libby, Heidi T. May, Joseph B. Muhlestein, John Nelson, Anna Nicolaou, Sion Roy, Kashif Shaikh, Chandana Shekar, John A. Tayek, Luke Zheng, Deepak L. Bhatt, Matthew J. Budoff

Bibliographic record

VenueFrontiers in Cardiovascular Medicine · 2023
Typearticle
Languageen
FieldMedicine
TopicCardiac Imaging and Diagnostics
Canadian institutionsnot available
FundersDaiichi Sankyo EuropeNational Heart, Lung, and Blood InstituteSt. Jude MedicalHLS TherapeuticsIdorsia PharmaceuticalsAssistance publique-Hôpitaux de ParisPfizerModernaMedicines CompanyRegado BiosciencesBelvoir Media GroupAmarin PharmaMyoKardiaNovo NordiskAstraZenecaAmarin CorporationIronwood Pharmaceuticals, IncorporatedNational Institutes of HealthRegeneron PharmaceuticalsDuke Clinical Research InstituteEisaiBrigham and Women's HospitalBoston VA Research InstituteBoston Scientific CorporationEli Lilly and CompanyCleveland ClinicBristol-Myers SquibbCSL BehringAlnylam PharmaceuticalsAmgenSanofiAmerican Heart Association
KeywordsMedicinePlaceboFibrous capVulnerable plaqueCoronary artery diseaseInternal medicineCardiologyRadiologyPathology

Abstract

fetched live from OpenAlex

Aims Residual cardiovascular risk persists despite statin therapy. In REDUCE-IT, icosapent ethyl (IPE) reduced total events, but the mechanisms of benefit are not fully understood. EVAPORATE evaluated the effects of IPE on plaque characteristics by coronary computed tomography angiography (CCTA). Given the conclusion that the IPE-treated patients demonstrate that plaque burden decreases has already been published in the primary study analysis, we aimed to demonstrate whether the use of an analytic technique defined and validated in histological terms could extend the primary study in terms of whether such changes could be reliably seen in less time on drug, at the individual (rather than only at the cohort) level, or both, as neither of these were established by the primary study result. Methods and Results EVAPORATE randomized the patients to IPE 4 g/day or placebo. Plaque morphology, including lipid-rich necrotic core (LRNC), fibrous cap thickness, and intraplaque hemorrhage (IPH), was assessed using the ElucidVivo® (Elucid Bioimaging Inc.) on CCTA. The changes in plaque morphology between the treatment groups were analyzed. A neural network to predict treatment assignment was used to infer patient representation that encodes significant morphological changes. Fifty-five patients completed the 18-month visit in EVAPORATE with interpretable images at each of the three time points. The decrease of LRNC between the patients on IPE vs. placebo at 9 months (reduction of 2 mm 3 vs. an increase of 41 mm 3 , p = 0.008), widening at 18 months (6 mm 3 vs. 58 mm 3 increase, p = 0.015) were observed. While not statistically significant on a univariable basis, reductions in wall thickness and increases in cap thickness motivated multivariable modeling on an individual patient basis. The per-patient response assessment was possible using a multivariable model of lipid-rich phenotype at the 9-month follow-up, p < 0.01 (sustained at 18 months), generalizing well to a validation cohort. Conclusion Plaques in the IPE-treated patients acquired more characteristics of stability. Reliable assessment using histologically validated analysis of individual response is possible at 9 months, with sustained stabilization at 18 months, providing a quantitative basis to elucidate drug mechanism and assess individual patient response.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.390
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.270
Teacher spread0.253 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations9
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in Cardiovascular MedicineSame topicCardiac Imaging and DiagnosticsFrench-language works237,207